North Carolina State University
Raleigh, North Carolina, United States
Purpose
to exploit non-lytic bacteriophage for treating enteric infections in low resource settings by engineering them to encode a CRISPR-Cas9 defense system targeted to pathogenic bacteria such as Shigella.
Division
Global Health
Date
October 2015
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Raleigh, North Carolina, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.